Home   Logon   Mobile Site   Research and Commentary   About Us   Call 1.800.621.1675 or Email Us       Follow Us: 

Search by Ticker, Keyword or CUSIP       


Nasdaq® Dividend Achievers 25 Portfolio, Series 11
Ticker Symbol: FDAERX

Ticker Company Name Initial
ADM Archer-Daniels-Midland Company 4% $40.09
AIZ Assurant, Inc. 4% 99.23
BG Bunge Limited 4% 67.99
CAH Cardinal Health, Inc. 4% 63.23
CLX The Clorox Company 4% 144.99
CMI Cummins Inc. 4% 177.06
CVS CVS Health Corporation 4% 73.52
EV Eaton Vance Corp. 4% 56.77
GPS The Gap, Inc. 4% 33.87
HAS Hasbro, Inc. 4% 92.08
IBM International Business Machines Corporation 4% 154.25
IVZ Invesco Ltd. 4% 36.35
JNJ Johnson & Johnson 4% 139.23
LMT Lockheed Martin Corporation 4% 318.54
MCD McDonald’s Corporation 4% 173.22
MDT Medtronic Plc 4% 82.21
MDP Meredith Corporation 4% 65.20
NEE NextEra Energy, Inc. 4% 155.09
SBSI Southside Bancshares, Inc. 4% 34.00
SWX Southwest Gas Holdings, Inc. 4% 79.74
TGT Target Corporation 4% 67.63
TXN Texas Instruments Incorporated 4% 105.57
UTX United Technologies Corporation 4% 128.16
WBA Walgreens Boots Alliance, Inc. 4% 74.95
WSM Williams-Sonoma, Inc. 4% 52.70

* As of the close of business on 1/2/18.
Market values are for reference only and are not indicative of your individual cost basis.

Not FDIC Insured • Not Bank Guaranteed • May Lose Value

Portfolio Summary
Initial Date of Deposit 1/3/2018
Initial Public Offering Price $10.00 per Unit
Portfolio Ending Date 1/3/2020
Estimated Net First Year Distribution per Unit* $0.2342
Estimated Net Subsequent Year Distribution per Unit* $0.2319
Cash CUSIP 30306F526
Reinvestment CUSIP 30306F534
Fee Accounts Cash CUSIP 30306F542
Fee Accounts Reinvestment CUSIP 30306F559

*The estimates are based on annualizing the most recent dividends declared by the issuers of the securities included in the portfolio. The estimated net annual distribution for the subsequent year is expected to be less than the amount for the first year because a portion of the securities included in the portfolio will be sold during the first year to pay for organization costs, the deferred sales charge and the creation and development fee. There is no guarantee that the issuers of the securities included in the portfolio will declare dividends in the future or that, if declared, they will remain at current levels or increase over time.

Sales Charges (based on a $10 public offering price)
Standard Accounts
Transactional Sales Charges: Initial: 0.00%
  Deferred: 2.25%
Creation & Development Fee:   0.50%
Maximum Sales Charge:   2.75%

The deferred sales charge will be deducted in three monthly installments commencing 4/20/18.

When the public offering price is less than or equal to $10.00 per unit, there will be no initial sales charge. If the price exceeds $10.00 per unit, you will pay an initial sales charge.

Fee/Wrap Accounts
Maximum Sales Charge: 0.50%

The maximum sales charge for investors in fee accounts consists of the creation and development fee. Investors in fee accounts are not assessed any transactional sales charges. Standard accounts sales charges apply to units purchased as an ineligible asset.

The creation and development fee is a charge of $.050 per unit collected at the end of the initial offering period. If the price you pay exceeds $10 per unit, the creation and development fee will be less than 0.50%; if the price you pay is less than $10 per unit, the creation and development fee will exceed 0.50%.

In addition to the sales charges listed, UITs are subject to annual operating expenses and organization costs.

You should consider the portfolio's investment objective, risks, and charges and expenses carefully before investing. Contact your financial advisor or call First Trust Portfolios, L.P. at 1.800.621.1675 to request a prospectus, which contains this and other information about the portfolio. Read it carefully before you invest.

Nasdaq® and NASDAQ US Broad Dividend Achievers IndexTM are registered trademarks of Nasdaq, Inc. (which with its affiliates are the Corporations) and are licensed for use by First Trust Portfolios L.P. The portfolio has not been passed on by the Corporations as to its legality or suitability. The portfolio is not issued, endorsed, sold, or promoted by the Corporations. THE CORPORATIONS MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO THE PORTFOLIO.

Risk Considerations:

An investment in this unmanaged unit investment trust should be made with an understanding of the risks involved with owning common stocks, such as an economic recession and the possible deterioration of either the financial condition of the issuers of the equity securities or the general condition of the stock market.

You should be aware that the portfolio is concentrated in stocks in the consumer products sector which involves additional risks, including limited diversification. The companies engaged in the consumer products industry are subject to global competition, changing government regulations and trade policies, currency fluctuations, and the financial and political risks inherent in producing products for foreign markets.

An investment in a portfolio containing small-cap and mid-cap companies is subject to additional risks, as the share prices of small-cap companies and certain mid-cap companies are often more volatile than those of larger companies due to several factors, including limited trading volumes, products, financial resources, management inexperience and less publicly available information.

An investment in a portfolio containing equity securities of foreign issuers is subject to additional risks, including currency fluctuations, political risks, withholding, the lack of adequate financial information, and exchange control restrictions impacting foreign issuers.

This UIT is a buy and hold strategy and investors should consider their ability to hold the trust until maturity. There may be tax consequences unless units are purchased in an IRA or other qualified plan.

The value of the securities held by the trust may be subject to steep declines or increased volatility due to changes in performance or perception of the issuers.

Fund Cusip Information
30306F526 (Cash)
30306F534 (Reinvest)
30306F542 (Cash-Fee)
30306F559 (Reinvest-Fee)
Printer Friendly Page Printer Friendly Page
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA and the Internal Revenue Code. First Trust has no knowledge of and has not been provided any information regarding any investor. Financial advisors must determine whether particular investments are appropriate for their clients. First Trust believes the financial advisor is a fiduciary, is capable of evaluating investment risks independently and is responsible for exercising independent judgment with respect to its retirement plan clients.
First Trust Portfolios L.P.  Member SIPC and FINRA.
First Trust Advisors L.P.
Home |  Important Legal Information |  Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2018 All rights reserved.